vs
AMERICAN SHARED HOSPITAL SERVICES（AMS）与RadNet, Inc.（RDNT）财务数据对比。点击上方公司名可切换其他公司
RadNet, Inc.的季度营收约是AMERICAN SHARED HOSPITAL SERVICES的70.9倍（$547.7M vs $7.7M）。RadNet, Inc.净利率更高（-0.1% vs -8.2%，领先8.1%）。RadNet, Inc.同比增速更快（14.8% vs -14.8%）。过去两年AMERICAN SHARED HOSPITAL SERVICES的营收复合增速更高（21.7% vs 12.6%）
美国共享医院服务公司为医疗机构提供放射治疗、立体定向放射外科及诊断成像设备的整体外包解决方案，免除医院高昂的前期资本投入，主要业务覆盖北美，同时服务拉美及部分亚太地区的公立、私立医院客户。
RadNet是美国领先的放射医疗服务企业，总部位于加利福尼亚州洛杉矶，是美国规模最大的独立固定地址诊断影像中心运营商，按网点数量及年度影像业务收入计均居行业首位。截至2025年，该公司在全美8个州持有或运营超400家影像中心，提供门诊诊断影像服务。
AMS vs RDNT — 直观对比
营收规模更大
RDNT
是对方的70.9倍
$7.7M
营收增速更快
RDNT
高出29.6%
-14.8%
净利率更高
RDNT
高出8.1%
-8.2%
两年增速更快
AMS
近两年复合增速
12.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $7.7M | $547.7M |
| 净利润 | $-631.0K | $-597.0K |
| 毛利率 | 11.7% | — |
| 营业利润率 | -18.1% | 5.1% |
| 净利率 | -8.2% | -0.1% |
| 营收同比 | -14.8% | 14.8% |
| 净利润同比 | 52.5% | -111.2% |
| 每股收益（稀释后） | $-0.09 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMSRDNT
| Q4 25 | $7.7M | $547.7M | ||
| Q3 25 | $7.2M | $522.9M | ||
| Q2 25 | $7.1M | $498.2M | ||
| Q1 25 | $6.1M | $471.4M | ||
| Q4 24 | $9.1M | $477.1M | ||
| Q3 24 | $7.0M | $461.1M | ||
| Q2 24 | $7.1M | $459.7M | ||
| Q1 24 | $5.2M | $431.7M |
净利润AMSRDNT
| Q4 25 | $-631.0K | $-597.0K | ||
| Q3 25 | $-17.0K | $5.4M | ||
| Q2 25 | $-280.0K | $14.5M | ||
| Q1 25 | $-625.0K | $-37.9M | ||
| Q4 24 | $-1.3M | $5.3M | ||
| Q3 24 | $-207.0K | $3.2M | ||
| Q2 24 | $3.6M | $-3.0M | ||
| Q1 24 | $119.0K | $-2.8M |
毛利率AMSRDNT
| Q4 25 | 11.7% | — | ||
| Q3 25 | 22.1% | — | ||
| Q2 25 | 23.1% | — | ||
| Q1 25 | 15.4% | — | ||
| Q4 24 | 35.3% | — | ||
| Q3 24 | 19.6% | — | ||
| Q2 24 | 35.0% | — | ||
| Q1 24 | 41.1% | — |
营业利润率AMSRDNT
| Q4 25 | -18.1% | 5.1% | ||
| Q3 25 | -4.8% | 5.2% | ||
| Q2 25 | -7.7% | 6.2% | ||
| Q1 25 | -21.3% | -5.1% | ||
| Q4 24 | -20.2% | 5.1% | ||
| Q3 24 | -12.7% | 7.4% | ||
| Q2 24 | -0.0% | 7.6% | ||
| Q1 24 | -1.6% | 2.6% |
净利率AMSRDNT
| Q4 25 | -8.2% | -0.1% | ||
| Q3 25 | -0.2% | 1.0% | ||
| Q2 25 | -4.0% | 2.9% | ||
| Q1 25 | -10.2% | -8.0% | ||
| Q4 24 | -14.6% | 1.1% | ||
| Q3 24 | -3.0% | 0.7% | ||
| Q2 24 | 51.0% | -0.6% | ||
| Q1 24 | 2.3% | -0.6% |
每股收益（稀释后）AMSRDNT
| Q4 25 | $-0.09 | $0.00 | ||
| Q3 25 | $0.00 | $0.07 | ||
| Q2 25 | $-0.04 | $0.19 | ||
| Q1 25 | $-0.10 | $-0.51 | ||
| Q4 24 | $-0.21 | $0.08 | ||
| Q3 24 | $-0.03 | $0.04 | ||
| Q2 24 | $0.55 | $-0.04 | ||
| Q1 24 | $0.02 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5M | $767.2M |
| 总债务越低越好 | $17.4M | $1.1B |
| 股东权益账面价值 | $24.0M | $1.1B |
| 总资产 | $55.5M | $3.8B |
| 负债/权益比越低杠杆越低 | 0.72× | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资AMSRDNT
| Q4 25 | $3.5M | $767.2M | ||
| Q3 25 | $5.1M | $804.7M | ||
| Q2 25 | $11.1M | $833.2M | ||
| Q1 25 | $11.2M | $717.3M | ||
| Q4 24 | $11.0M | $740.0M | ||
| Q3 24 | $13.8M | $748.9M | ||
| Q2 24 | $14.2M | $741.7M | ||
| Q1 24 | $12.8M | $527.0M |
总债务AMSRDNT
| Q4 25 | $17.4M | $1.1B | ||
| Q3 25 | $18.2M | $1.1B | ||
| Q2 25 | $19.1M | $1.1B | ||
| Q1 25 | $19.9M | $1.0B | ||
| Q4 24 | $20.4M | $1.0B | ||
| Q3 24 | $14.4M | $1.0B | ||
| Q2 24 | $15.1M | $1.0B | ||
| Q1 24 | $15.6M | $834.6M |
股东权益AMSRDNT
| Q4 25 | $24.0M | $1.1B | ||
| Q3 25 | $24.6M | $1.1B | ||
| Q2 25 | $24.5M | $932.3M | ||
| Q1 25 | $24.6M | $898.1M | ||
| Q4 24 | $25.2M | $902.3M | ||
| Q3 24 | $26.4M | $895.3M | ||
| Q2 24 | $26.5M | $881.0M | ||
| Q1 24 | $22.8M | $873.0M |
总资产AMSRDNT
| Q4 25 | $55.5M | $3.8B | ||
| Q3 25 | $59.6M | $3.7B | ||
| Q2 25 | $63.5M | $3.5B | ||
| Q1 25 | $63.3M | $3.3B | ||
| Q4 24 | $60.2M | $3.3B | ||
| Q3 24 | $63.3M | $3.3B | ||
| Q2 24 | $60.8M | $3.2B | ||
| Q1 24 | $50.1M | $3.0B |
负债/权益比AMSRDNT
| Q4 25 | 0.72× | 1.00× | ||
| Q3 25 | 0.74× | 1.04× | ||
| Q2 25 | 0.78× | 1.18× | ||
| Q1 25 | 0.81× | 1.12× | ||
| Q4 24 | 0.81× | 1.13× | ||
| Q3 24 | 0.54× | 1.14× | ||
| Q2 24 | 0.57× | 1.17× | ||
| Q1 24 | 0.68× | 0.96× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-704.0K | $84.2M |
| 自由现金流经营现金流 - 资本支出 | $-2.7M | — |
| 自由现金流率自由现金流/营收 | -34.8% | — |
| 资本支出强度资本支出/营收 | 25.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-8.5M | — |
8季度趋势，按日历期对齐
经营现金流AMSRDNT
| Q4 25 | $-704.0K | $84.2M | ||
| Q3 25 | $1.7M | $52.8M | ||
| Q2 25 | $-372.0K | $120.3M | ||
| Q1 25 | $2.5M | $41.5M | ||
| Q4 24 | $274.0K | $42.5M | ||
| Q3 24 | $472.0K | $57.4M | ||
| Q2 24 | $1.3M | $116.0M | ||
| Q1 24 | $-1.9M | $17.1M |
自由现金流AMSRDNT
| Q4 25 | $-2.7M | — | ||
| Q3 25 | $-2.0M | — | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-1.5M | — | ||
| Q4 24 | $-4.4M | — | ||
| Q3 24 | $-407.0K | — | ||
| Q2 24 | $70.0K | — | ||
| Q1 24 | $-3.0M | — |
自由现金流率AMSRDNT
| Q4 25 | -34.8% | — | ||
| Q3 25 | -28.3% | — | ||
| Q2 25 | -32.1% | — | ||
| Q1 25 | -24.7% | — | ||
| Q4 24 | -48.4% | — | ||
| Q3 24 | -5.8% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | -58.4% | — |
资本支出强度AMSRDNT
| Q4 25 | 25.7% | — | ||
| Q3 25 | 51.6% | — | ||
| Q2 25 | 26.9% | — | ||
| Q1 25 | 65.7% | — | ||
| Q4 24 | 51.4% | — | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 17.2% | — | ||
| Q1 24 | 22.7% | — |
现金转化率AMSRDNT
| Q4 25 | — | — | ||
| Q3 25 | — | 9.75× | ||
| Q2 25 | — | 8.33× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 7.96× | ||
| Q3 24 | — | 17.89× | ||
| Q2 24 | 0.36× | — | ||
| Q1 24 | -15.67× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMS
| Direct Patient Services | $4.0M | 51% |
| Rental Income From Medical Services | $2.7M | 35% |
| Pbrt Services | $1.2M | 15% |
RDNT
| Commercial Insurance1 | $301.0M | 55% |
| Medicare1 | $129.2M | 24% |
| Capitation Arrangements | $31.9M | 6% |
| Health Care Other | $20.4M | 4% |
| Digital Health | $16.4M | 3% |
| Other | $15.2M | 3% |
| Medicaid1 | $14.0M | 3% |
| Workers Compensation Personal Injury1 | $12.3M | 2% |
| Health Care Management Service | $7.5M | 1% |
